Study guide

8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation

PEBC Pharmacist Evaluating Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & The Canadian Pharmacy Practice Landscape

1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway 1.2 The Canadian Healthcare System, Canada Health Act, and Drug Regulation 1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation

2 Chapter 2: Pharmaceutics & Drug Delivery Systems

2.1 Physicochemical Principles, Solubility, Ionization, and Stability 2.2 Solid Dosage Forms, Formulation Science, and Modified-Release Technologies 2.3 Liquid and Semisolid Dosage Forms, Dispersions, and Topical Delivery 2.4 Sterile Product Principles, Parenteral Delivery, and Biopharmaceuticals 2.5 Pharmaceutical Quality: GMP, Stability Testing, and Bioequivalence

3 Chapter 3: Biopharmaceutics & Clinical Pharmacokinetics

3.1 Drug Absorption, Distribution, Metabolism, and Elimination (ADME) 3.2 Bioavailability, Bioequivalence, and Biopharmaceutics Classification System (BCS) 3.3 Pharmacokinetic Modeling, Parameters, and Dosing Calculations 3.4 Therapeutic Drug Monitoring (TDM) and Clinical Application

4 Chapter 4: Pharmacology, Toxicology & Pharmacogenetics

4.1 Autonomic and Central Nervous System Pharmacology 4.2 Cardiovascular, Renal, and Endocrine Pharmacology 4.3 Clinical Toxicology, Overdose Management, and Antidotes 4.4 Biologics, Biosimilars, and Pharmacogenetics

5 Chapter 5: Pathophysiology & Clinical Assessment

5.1 Clinical Laboratory Diagnostics, Biomarkers, and Vital Signs 5.2 Cardiovascular and Respiratory Pathophysiology 5.3 Endocrine, Renal, and Gastrointestinal Pathophysiology 5.4 Neurologic, Psychiatric, and Musculoskeletal Pathophysiology 5.5 Physical Assessment and Point-of-Care Testing

6 Chapter 6: Pharmacotherapy & Minor Ailments

6.1 Cardiovascular Pharmacotherapy & Evidence-Based Guidelines 6.2 Endocrine and Metabolic Pharmacotherapy 6.3 Infectious Diseases and Antimicrobial Stewardship 6.4 Neurologic, Psychiatric, and Pain Management Therapeutics 6.5 Minor Ailment Prescribing and Nonprescription Therapy 6.6 Respiratory Pharmacotherapy: Asthma, COPD, and Inhaled Therapy 6.7 Gastrointestinal and Hepatic Pharmacotherapy 6.8 Renal, Fluid, and Electrolyte Therapeutics 6.9 Musculoskeletal and Rheumatologic Pharmacotherapy 6.10 Dermatologic, Ophthalmic, and Ear-Nose-Throat Pharmacotherapy 6.11 Hematologic, Immunologic, and Oncology Supportive Care 6.12 Women's Health, Men's Health, and Urologic Therapeutics 6.13 Nutrition, Natural Health Products, and Complementary Medicine

7 Chapter 7: Special Populations & Applied Therapeutics

7.1 Geriatric Pharmacotherapy and Deprescribing 7.2 Pediatric and Neonatal Pharmacotherapy 7.3 Perinatal Pharmacotherapy: Pregnancy and Lactation 7.4 Dosage Adjustments in Renal and Hepatic Impairment

8 Chapter 8: Prescription Processing, Calculations & Compounding

8.1 Prescription Processing, Verification, and Drug Therapy Problem Management 8.2 Pharmaceutical Calculations and Clinical Math 8.3 Non-Sterile Compounding and NAPRA Standards 8.4 Sterile and Hazardous Compounding under NAPRA Standards 8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation

9 Chapter 9: Health Equity, Indigenous Health & Pharmacy Bioethics

9.1 Social Determinants of Health and Health Equity 9.2 Indigenous Health, Cultural Safety, and Humility 9.3 Pharmacy Bioethics, Informed Consent, and Professional Boundaries 9.4 Health Promotion, Disease Prevention, and Public Health

10 Chapter 10: Evidence Appraisal, Safety & Practice Management

10.1 Biostatistics and Critical Appraisal of Clinical Literature 10.2 Pharmacoeconomics and Pharmacoepidemiology 10.3 Medication Safety, Incident Analysis, and Quality Improvement 10.4 Pharmacy Operations, Cold-Chain Management, and Emergency Preparedness 10.5 Drug Information and Evidence-Based Decision Making 10.6 Pharmacovigilance and Adverse Drug Reaction Reporting in Canada

11 Chapter 11: Patient Care Process, Communication & Collaborative Practice

11.1 The Patient Care Process: Assessment, Care Plans, and Follow-Up 11.2 Patient and Caregiver Communication, Education, and Health Literacy 11.3 Motivational Interviewing and Shared Decision-Making 11.4 Intra- and Interprofessional Collaborative Care

12 Chapter 12: Medication Administration, Devices & Expanded Scope

12.1 Injection and Vaccine Administration Technique 12.2 Immunization Schedules, Vaccine Selection, and Travel Health 12.3 Home Medical Devices and Device Technique Coaching 12.4 Expanded Scope: Adapting, Renewing, Initiating, and Medication Reconciliation

13 Chapter 13: Pharmacy Management, Finance & Practice Leadership

13.1 Human Resources, Leadership, and Change Management 13.2 Financial Management, Drug Plans, and Marketing 13.3 Quality Improvement, Risk Management, and Workplace Safety

8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation

Key Takeaways Explain This Topic AI

The PEBC reference sheet supplied during the examination gives creatinine clearance for males as (140 minus age) times actual body weight in kilograms times 1.2, divided by serum creatinine in micromoles per litre, with the female value being 0.85 times the male result.

Body mass index is weight in kilograms divided by height in metres squared, and it appears on the same provided reference sheet.

Infusion rate in millilitres per hour is the ordered dose per hour divided by the concentration of the prepared bag.

Steady-state concentration during a continuous infusion equals the infusion rate divided by the product of the elimination rate constant and the volume of distribution.

Parenteral nutrition energy is calculated as 4 kcal per gram of protein and carbohydrate from dextrose at 3.4 kcal per gram, with lipid emulsion contributing about 9 kcal per gram of fat.

Last updated: August 2026

8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation

Exam Focus: Prescription calculations are a named subcategory of Pharmacy Practice. The examination is closed-book, but an on-screen scientific calculator and a PEBC reference sheet of formulas are provided , so the skill being tested is selecting and applying the right relationship, not recalling constants.

The Provided Reference Sheet

The PEBC Pharmacist Evaluating Examination reference sheet supplies the pharmacokinetic and clinical formulas below. Learn to recognise which one a question needs.

  • Quantity Relationship as supplied
  • Concentration at time t C equals C0 times e to the power of negative ke times t
  • Half-life t1/2 equals 0.693 divided by ke
  • Shelf life t90 equals 0.105 divided by ke
  • Total clearance Cl equals F times D divided by AUC
  • Volume of distribution Vd equals D divided by C0
  • Clearance from Vd Cl equals Vd times ke
  • Steady-state concentration on infusion Css equals R0 divided by (ke times Vd)
  • Average concentration Cave equals AUC over one dosing interval divided by that interval

Bioavailability F equals (AUC by the route divided by dose by that route) divided by (AUC intravenous divided by intravenous dose)

Creatinine clearance, male (140 minus age) times actual body weight in kg times 1.2, all divided by serum creatinine in micromol/L

  • Creatinine clearance, female 0.85 times the male result
  • Body mass index weight in kg divided by height in metres squared

Two points about the creatinine clearance formula matter for the examination. First, it takes serum creatinine in micromoles per litre , the SI unit used in Canada, and the numeric factor of 1.2 goes with those units; formulas written for milligrams per decilitre use different constants and are not what the reference sheet supplies. Second, the sheet specifies actual body weight . In clinical practice, ideal body weight is commonly substituted in underweight patients and adjusted body weight in obesity to avoid overestimating clearance, and a good answer recognises both the supplied formula and that clinical caveat.

Worked example. A 72-year-old woman weighs 62 kg with a serum creatinine of 108 micromol/L.

Male value: (140 − 72) × 62 × 1.2 ÷ 108 = 68 × 62 × 1.2 ÷ 108 = 5,059.2 ÷ 108 = 46.8 mL/min .

Female value: 0.85 × 46.8 = 39.8 mL/min .

That result places her in the range where several direct oral anticoagulants, gabapentin, and many antimicrobials require dose reduction.

Intravenous Infusion Rates

The governing relationship is simple and must be applied consistently in one set of units:

Rate (mL/h) = dose required per hour ÷ concentration of the prepared solution (per mL)

Worked example. Heparin 25,000 units in 250 mL is ordered at 1,100 units/h.

Concentration = 25,000 ÷ 250 = 100 units/mL. Rate = 1,100 ÷ 100 = 11 mL/h .

Weight-based example. Dopamine 400 mg in 250 mL, ordered at 5 mcg/kg/min for an 80 kg patient.

Dose per minute = 5 × 80 = 400 mcg/min = 0.4 mg/min.

Dose per hour = 0.4 × 60 = 24 mg/h.

Concentration = 400 mg ÷ 250 mL = 1.6 mg/mL.

Rate = 24 ÷ 1.6 = 15 mL/h .

Gravity drip rate converts volume to drops:

Drops per minute = (volume in mL × drop factor in drops/mL) ÷ time in minutes

For 1,000 mL over 8 hours with a 15 drops/mL set: (1,000 × 15) ÷ 480 = 31 drops per minute .

Milliequivalents, Millimoles, and Osmolarity

Milliequivalents: mEq = (mg × valence) ÷ molecular weight. For potassium chloride (molecular weight 74.5, valence 1), 1 g supplies 1,000 ÷ 74.5 = 13.4 mEq .

Millimoles: mmol = mg ÷ molecular weight. Phosphate is ordered in millimoles rather than milliequivalents because its valence varies with pH.

Osmolarity: mOsm/L = (grams per litre ÷ molecular weight) × number of dissociated species × 1,000. Sodium chloride 0.9% supplies 9 g/L; 9 ÷ 58.5 × 2 × 1,000 = 308 mOsm/L , which is why normal saline is very close to plasma osmolarity.

Peripheral infusions are generally limited to about 900 mOsm/L; more concentrated parenteral nutrition requires central access.

Parenteral Nutrition

Energy contributions differ from the familiar dietary values because dextrose in solution is monohydrated:

  • Macronutrient Energy
  • Dextrose (intravenous) 3.4 kcal per gram
  • Protein or amino acids 4 kcal per gram
  • Lipid emulsion About 9 kcal per gram of fat; a 20% emulsion supplies about 2 kcal per mL

Worked example. A parenteral nutrition bag contains 500 mL of 50% dextrose, 500 mL of 8.5% amino acids, and 250 mL of 20% lipid.

Dextrose: 500 mL × 0.50 = 250 g → 250 × 3.4 = 850 kcal .

Amino acids: 500 mL × 0.085 = 42.5 g → 42.5 × 4 = 170 kcal .

Lipid: 250 mL × 0.20 = 50 g fat → 50 × 9 = 450 kcal .

Total ≈ 1,470 kcal in a total volume of 1,250 mL.

Protein energy is often reported separately as non-protein calories when calculating the non-protein calorie to nitrogen ratio, where nitrogen equals grams of protein divided by 6.25.

Isotonicity

Ophthalmic, nasal, and parenteral preparations should be approximately isotonic with body fluids, equivalent to 0.9% sodium chloride .

The sodium chloride equivalent (E value) is the mass of sodium chloride producing the same osmotic effect as 1 g of the drug.

Sodium chloride needed (g) = (0.009 × volume in mL) − (weight of drug in g × E value)

Worked example. Prepare 30 mL of a 1% solution of a drug with an E value of 0.20.

Sodium chloride to make 30 mL isotonic alone: 0.009 × 30 = 0.27 g.

Drug present: 0.3 g; its sodium chloride equivalent contribution = 0.3 × 0.20 = 0.06 g.

Sodium chloride to add = 0.27 − 0.06 = 0.21 g .

Checking Your Work

Three habits prevent most calculation errors on this examination:

Carry the units through every step and confirm the final unit is the one asked for.

Estimate the order of magnitude first. A paediatric dose calculated as 4,000 mg, or an infusion rate of 900 mL/h, is wrong before the arithmetic is checked.

Re-read what was asked. Questions frequently ask for millilitres per hour when the calculation naturally produces milligrams per hour, or for the volume of the concentrate rather than the volume of the final preparation.

Remember the examination's numeric conventions: values are given in SI units, a period is the decimal separator in English, and a trailing zero may appear in a printed value even though the Institute for Safe Medication Practices discourages it in practice.